| Dr Ayman Tarabishy, MD | |
|
34020 7 Mile Rd Ste 101, Livonia, MI 48152-3093 | |
| (248) 516-5016 | |
| (248) 516-5017 |
| Full Name | Dr Ayman Tarabishy |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 16 Years |
| Location | 34020 7 Mile Rd Ste 101, Livonia, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568751550 | NPI | - | NPPES |
| 1568751550 | Medicaid | MI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Macomb Hospital | Clinton township, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ayman Tarabishy Md Pllc | 0446521850 | 6 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Entity Name | Northland Radiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386804060 PECOS PAC ID: 7719884741 Enrollment ID: O20040214000016 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Entity Name | Jawad A Shah, Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942402391 PECOS PAC ID: 5799779633 Enrollment ID: O20040413000798 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Entity Name | Michigan Sports And Spine Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205887262 PECOS PAC ID: 0749243467 Enrollment ID: O20041104000371 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Entity Name | Michigan Interventional Pain Center,pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053356774 PECOS PAC ID: 5799797452 Enrollment ID: O20060620000137 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Entity Name | Michigan Healthcare Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275858862 PECOS PAC ID: 2466626270 Enrollment ID: O20111114000025 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Entity Name | Best Urgent Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952791105 PECOS PAC ID: 4082930722 Enrollment ID: O20150224001082 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Entity Name | Ayman Tarabishy Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548624984 PECOS PAC ID: 0446521850 Enrollment ID: O20170803001387 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ayman Tarabishy, MD Po Box 30148, Belfast, ME 04915-2053 Ph: (888) 488-8289 | Dr Ayman Tarabishy, MD 34020 7 Mile Rd Ste 101, Livonia, MI 48152-3093 Ph: (248) 516-5016 |
News Archive
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Researchers from the Emory University have developed a new phone app that needs just a colour photograph of the nail beds of an individual to detect anemia in them. The results of the report titled, "Smartphone app for non-invasive detection of anemia using only patient-sourced photos," were published in the latest issue of the journal Nature Communications.
Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 3 days ago
Jeff Scott Pierce, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 18312 Middlebelt Rd, Livonia, MI 48152 Phone: 248-680-9000 Fax: 248-680-2929 | |
Dr. Ranjini Satyadev, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 14555 Levan Rd., #314, Livonia, MI 48154 Phone: 734-464-4138 Fax: 734-293-5379 | |
Icelle Grace Villanueva Martinez, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 36313 St Andrews Dr, Livonia, MI 48152 Phone: 248-805-2622 | |
Mrs. Urszula Michalski, RPTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 38777 West Six Mile Road, Suite 209 Supplemental Health Care, Livonia, MI 48152 Phone: 734-452-0395 Fax: 734-779-1361 | |
Dr. Steven Russell Hinderer, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 34020 7 Mile Rd Ste 102, Livonia, MI 48152 Phone: 734-622-9500 Fax: 734-622-9555 | |
Dr. Arti Patel Amin, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 14555 Levan Rd, Ste 314, Livonia, MI 48154 Phone: 734-542-1970 Fax: 734-293-5379 |